Market Research Logo

Europe Migraine Epidemiology and Patient Flow Analysis - 2017

Europe Migraine Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Migraine patients study in a new report ‘Europe Migraine Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Migraine derived from epidemiological analysis, percentage of patients diagnosed with Migraine, and percentage of patients treated with a therapy.

The study helps executives estimate Migraine market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Migraine prevalence, Migraine diagnosis rate, and Migraine treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Migraine Patient Flow
  • Migraine Prevalence
  • Migraine Diagnosed Patients
  • Migraine Treated Patients


1. Migraine: Disease Definition
2. Migraine Patient Flow in Europe
2A. Migraine Prevalence in Europe
2B. Migraine Diagnosed Patients in Europe
2C. Migraine Treated Patients in Europe
3. Migraine Patient Flow in Germany
3A. Migraine Prevalence in Germany
3B. Migraine Diagnosed Patients in Germany
3C. Migraine Treated Patients in Germany
4. Migraine Patient Flow in France
4A. Migraine Prevalence in France
4B. Migraine Diagnosed Patients in France
4C. Migraine Treated Patients in France
5. Migraine Patient Flow in Spain
5A. Migraine Prevalence in Spain
5B. Migraine Diagnosed Patients in Spain
5C. Migraine Treated Patients in Spain
6. Migraine Patient Flow in Italy
6A. Migraine Prevalence in Italy
6B. Migraine Diagnosed Patients in Italy
6C. Migraine Treated Patients in Italy
7. Migraine Patient Flow in UK
7A. Migraine Prevalence in UK
7B. Migraine Diagnosed Patients in UK
7C. Migraine Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Migraine Patient Flow in Europe, 2016
Table 2: Migraine Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Migraine Patient Flow in Germany, 2016
Table 4: Migraine Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Migraine Patient Flow in France, 2016
Table 6: Migraine Patient Flow Forecast in France, 2016 - 2025
Table 7: Migraine Patient Flow in Spain, 2016
Table 8: Migraine Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Migraine Patient Flow in Italy, 2016
Table 10: Migraine Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Migraine Patient Flow in UK, 2016
Table 12: Migraine Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Migraine Patient Flow in Europe, 2016
Figure 2: Migraine Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Migraine Patient Flow in Germany, 2016
Figure 4: Migraine Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Migraine Patient Flow in France, 2016
Figure 6: Migraine Patient Flow Forecast in France, 2016 - 2025
Figure 7: Migraine Patient Flow in Spain, 2016
Figure 8: Migraine Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Migraine Patient Flow in Italy, 2016
Figure 10: Migraine Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Migraine Patient Flow in UK, 2016
Figure 12: Migraine Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report